|1|Sonographic features of peripheral nerves at multiple sites in patients with diabetic polyneuropathy. (26782023)
Kang S.... Yoon J.S.
|2|Effect of Ranirestat on Sensory and Motor Nerve Function in Japanese Patients with Diabetic Polyneuropathy: A Randomized Double-Blind Placebo-Controlled Study. (26881251)
Satoh J.... Yamaguchi Y.
|3|An 'Importance' Map of Signs and Symptoms to Classify Diabetic Polyneuropathy: An Exploratory Data Analysis. (26075711)
Sacco I.C.... Sartor C.D.
|4|Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and A/-opioid receptor agonism. (25697471)
Schiene K.... Christoph T.
|5|Reduced skeletal muscle quantity and quality in patients with diabetic polyneuropathy assessed by magnetic resonance imaging. (26202052)
Moore C.W.... Rice C.L.
|6|Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. (25802721)
Kondo M.... Nakamura J.
|7|Tapentadol prolonged release in the treatment of neuropathic pain related to diabetic polyneuropathy--authors' reply. (26067119)
Finnerup N.B.... Attal N.
|8|Diabetic polyneuropathy and the risk of developing diabetic retinopathy: a nationwide, population-based study. (25989925)
Lin I.C.... Wang I.J.
|9|Nerve conduction studies in diabetics presymptomatic and symptomatic for diabetic polyneuropathy. (26049172)
de Souza R.J.... Nagvekar M.D.
|10|Mobile biofeedback of heart rate variability in patients with diabetic polyneuropathy: a preliminary study. (24438496)
Druschky K.... Druschky A.
|11|Methodology for conduct of epidemiologic surveys and randomized controlled trials of diabetic polyneuropathy. (25410232)
|12|Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. (24713310)
Niesters M.... Dahan A.
|13|Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice. (24319678)
Himeno T.... Nakamura J.
|14|Whither pathogenetic treatments for diabetic polyneuropathy? (23381942)
Boulton A.J.... Ziegler D.
|15|Influence of a specific, biorhythmically defined physical stimulus on deficient vasomotion in small-caliber arterioles in the subcutis in patients with diabetic polyneuropathy. (24021603)
Klopp R.C.... Ruhnau K.J.
|16|Thermal threshold: research study on small fiber dysfunction in distal diabetic polyneuropathy. (22401337)
Jimenez-Cohl P.... Villaseca R.
|17|Clinical and electrophysiological signs of diabetic polyneuropathy -- effect of glycemia and duration of diabetes mellitus. (22263377)
Kovac B.... Demarin V.
|18|Letter: diabetic polyneuropathy and cardiovascular complications in type 2 diabetic patients (diabetes metab j 2011;35:390-6). (22111049)
Ko S.H.... Ko S.H.
|19|Power spectral analyses of index finger skin blood perfusion in carpal tunnel syndrome and diabetic polyneuropathy. (21716676)
Huang H.W.... Lin C.C.
|20|Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. (21941444)
McIlduff C.E.... Rutkove S.B.
|21|Efficacy and safety of antioxidant treatment with I+-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. (21775755)
Ziegler D.... Dyck P.J.
|22|Non-pharmacological correction of impaired microcirculation in children with diabetic polyneuropathy. (20151328)
Nikolaeva N.V.... Tkacheva E.N.
|23|A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. (20431806)
Mythili A.... Butchi R.G.
|24|A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. (19738078)
|25|The beneficial effects of C-Peptide on diabetic polyneuropathy. (20039008)
Kamiya H.... Sima A.A.
|26|Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. (18473286)
Stracke H.... Bretzel R.G.
|27|Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. (17478005)
Yasuda H.... Kashiwagi A.
|28|Strength-duration properties in diabetic polyneuropathy. (17408800)
Yerdelen D.... Sarica Y.
|29|Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow]. (18318116)
Spitsina E.V.... Nosikov V.V.
|30|Comparison of the utility of sympathetic skin response and current perception threshold examinations with conventional examinations for the early electrophysiological diagnosis of diabetic polyneuropathy. (17191732)
Ono S.... Mizutani T.
|31|Two-stage community-based screening model for estimating prevalence of diabetic polyneuropathy (KCIS no. 6). (15855798)
Hsu W.C.... Chen T.H.
|32|The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. (15154940)
KAostenbauer T.... Irsigler K.
|33|Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. (15210530)
Barbano R.L.... Dworkin R.H.
|34|Animal models of human diabetic polyneuropathy. (12684353)
Crawford C.L.... Hardwicke P.
|35|Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. (12610024)
Meijer J.W.... Hoogenberg K.
|36|New insights into diabetic polyneuropathy. (12966130)
Polydefkis M.... McArthur J.
|37|Hyperesthesia: an early manifestation of diabetic polyneuropathy. (12521185)
|38|Nerve growth factor (NGF) in treatment of diabetic polyneuropathy. One hope less?]. (11433707)
Quasthoff S.... Hartung H.P.
|39|The role of glycation in the pathogenesis of diabetic polyneuropathy. (11724915)
|40|Status of current clinical trials in diabetic polyneuropathy. (11513337)
|41|A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats. (10907124)
Sima A.A.... Yorek M.A.
|42|Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. (10595592)
Ziegler D.... Gries F.A.
|43|F-wave-duration in diabetic polyneuropathy. (9466603)
|44|Subacute uremic and diabetic polyneuropathy. (8995584)
Bolton C.F.... Remtulla H.
|45|Motor nerve refractory period distribution assessed by two techniques in diabetic polyneuropathy. (7521291)
Ruijten M.W.... Verberk M.M.
|46|A critical assessment of vascular factors in the causation of diabetic polyneuropathy. (8334845)
|47|Structural functional interactions in the natural history of diabetic polyneuropathy: a key to the understanding of neuropathic pain? (8334853)
|48|Diagnosis and therapy of diabetic polyneuropathy]. (8517070)
Stracke H.... Federlin K.
|49|Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. (1395463)
Valk G.D.... Bertelsmann F.W.
|50|Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud's phenomenon and diabetic polyneuropathy). (6982164)